Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quantitative SARS-CoV-2 Antibody Pre and Post Cardiopulmonary Bypass

NCT05357885 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT05357885
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05357885 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quantitative SARS-CoV-2 Antibody Pre and Post Cardiopulmonary Bypass
Lead sponsor
Thomas Jefferson University
Phase
Observational
Overall status
Completed
Start date
November 17, 2021
Completion date
March 17, 2022
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

laboratory assessment sars-cov-2 antibody levels before and after surgery for patients requiring cardiopulmonary bypass